General Information
|
|
Product
|
CD21 Positive Control
|
Description
|
Western Blot Positive Control Complement Receptor Type 2
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
Immunogen
|
Purified Protein
|
Accession #
|
NCBI: XP_011507508.1
|
Physical Properties
|
|
Quantity
|
5 Applications
|
Volume
|
Inquire
|
Form
|
Western Blot Positive Control
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
Western Blot
|
1:500
|
Protein
|
Uniprot #
|
P20023
|
Overview
|
Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRPU. Participates in B lymphocytes activation.
|
Molecular Function
|
Complement binding; DNA binding; Protein homodimerization activity
|
Subcellular Location
|
Membrane; Single-pass type I membrane protein
|
Expression
|
Mature B-lymphocytes, T-lymphocytes, pharyngeal epithelial cells, astrocytes and follicular dendritic cells of the spleen.
|
Structure
|
Interacts (via Sushi domain 1 and 2) with C3dg.
|
Alternative Nomenclature
|
C3DR antibody
CD21 antibody
CD21 antigen antibody
Complement C3d receptor antibody
Complement component (3d/Epstein Barr virus) receptor 2 antibody
Complement component receptor 2 antibody
Cr 2 antibody
CR antibody
CVID7 antibody
EBV receptor antibody
EBV-R antibody
Epstein Barr virus receptor antibody
EVBR antibody
SLEB9 antibody
|
|
|